CDR-Life is a biotherapeutics company developing novel therapies harnessing the power of the immune system. Today’s cancer immunotherapies are powerful but are not tumor targeted, which compromises both efficacy and safety. We are developing a next generation of highly tumor-selective immunotherapies to truly empower the immune system to eradicate malignant cells without the off-tumor-related limitations of current immunotherapies.
CDR-Life has developed the unique M-gager® technology to generate MHC-specific antibody-based T cell engagers that target highly tumor-specific intracellular antigens with unparalleled specificity. Our dual-MHC binding molecule format based on antibody fragments has the promise of developing new immunotherapies with high tumor cell killing potency, longer duration of effect, and lower risk of immune-related adverse effects.
CDR-Life is advancing a growing portfolio of novel and highly tumor-selective immunotherapies based on the M-gager® technology.
Location: Switzerland, Zurich, Schlieren
Employees: 11-50
Total raised: $76M
Founded date: 2017
Investors 3
| Date | Name | Website |
| 16.04.2022 | Jeito Capi... | jeito.life |
| 19.04.2022 | Omega Fund... | omegafunds... |
| 16.05.2022 | VentureLab | venturelab... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 14.04.2022 | Series A | $76M | Jeito Capi... |
Mentions in press and media 27
| Date | Title | Description | Source |
| 26.01.2024 | New milestones for life sciences startups | BioVersys AG is a clinical stage, multi-asset Swiss pharmaceutical company focusing on research and... | startuptic... |
| 14.12.2023 | CDR-Life advances into the clinical phase | startuptic... | |
| 03.08.2023 | CDR Life obtains milestone payment | startuptic... | |
| 02.09.2022 | Change of management in pursuit of growth | startuptic... | |
| 23.05.2022 | Swiss Biotechs display their innovations at BIO 2022 Interna... | startuptic... | |
| 14.04.2022 | Health tech fund raises $800 million as COVID speeds up chan... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 13.04.2022 | CDR-Life Announces $76 Million Raised in Series A Funding | ZÜRICH, Switzerland, April 13, 2022 (GLOBE NEWSWIRE) -- CDR-Life Inc., a biotechnology company pione... | globenewsw... |
| 13.04.2022 | Swiss biotech CDR Life uses $76M series A funding round to r... | Swiss biotech CDR Life has nabbed $76 million in series A bucks to flesh out its multispecific T-cel... | fiercebiot... |
| 13.04.2022 | CDR-Life Closes $76 million Series A Funding | startuptic... | |
| 13.04.2022 | CDR-Life raises USD 76 million in Series A funding to suppor... | CDR-Life raises USD 76 million in Series A funding to support advancement of its transformative canc... | venturelab... |
Show more